comparemela.com

Latest Breaking News On - Yuping sun - Page 1 : comparemela.com

QureBio Ltd to Present its Q-1802 Clinical Phase Ⅰ Data at 2023 ASCO-GI Meetings

/PRNewswire/ QureBio Ltd., a clinical-stage biopharmaceutical company focusing on development of bispecific antibodies and other engineered.

Xiangdong quJian zhangLin shenSan franciscoUnited statesYuping sunViva bioXiaohua chenTao yuYanqiao zhangJie houLi weiYusheng wangQin yuJifang gongYakun wang

Trial for drug targeting cancerous tumors begins in China

A phase 1 trial to investigate a drug for treating people with advanced malignant neoplasms has begun in China.

Yuping sunWeiguo suShanghai east hospitalShandong cancer

vimarsana © 2020. All Rights Reserved.